Recruiting Heart Attack Studies in Tulsa
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
The goal of this study is to provide sufficient therapy during the time a patients' B-cell Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) risk category is being determined. The ter...
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question th...
Artificial Intelligence to Measure Adherence to Oral Medication
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis....
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
This is a Phase II clinical trial testing the use of two antigen-directed therapies, inotuzumab and blinatumomab, as part of induction therapy for children and young adults with newly diagnosed B-cell...
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
This is a clinical trial testing whether the addition of one of two chemotherapy agents, dasatinib or venetoclax, can improve outcomes for children and young adults with newly diagnosed T-cell acute l...
About Heart Attack Clinical Trials in Tulsa
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 5 heart attack clinical trials recruiting participants in Tulsa, OK. These studies are seeking a combined 2,018 participants. Research is being sponsored by St. Jude Children's Research Hospital, Corxel Pharmaceuticals, Northwell Health. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Tulsa — FAQ
Are there heart attack clinical trials in Tulsa?
Yes, there are 5 heart attack clinical trials currently recruiting in Tulsa, OK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tulsa?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tulsa research site will contact you about next steps.
Are clinical trials in Tulsa free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tulsa studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 5 active trials in Tulsa are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov